The safety of sumatriptan administration 2 h after subcutaneous injection of alniditan, a new anti-migraine drug, in healthy volunteers

British Journal of Clinical Pharmacology

Volumn 41, Issue 5, 1996, Pages

  Kamali, F ^c   Tommey, R ^c   Wallace, R J ^a   Calvert, A ^a   Soons, P A ^b   Wooding, S J ^a  

^a Janssen Research Foundation   (United Kingdom)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0010446306     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Crabbe R, et al. Janssen Research Foundation, Clinical Research Report 1994; N101183.